Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?
2016
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)
2012
Design and test of a new multi-amplifier system with phase and amplitude control
1998
Hyperthermia in combined treatment of cancer
2002 Standout
Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience
2001
Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations
2003
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene
1999
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy
2002 Standout
Pulmonary Toxicity Associated With the Treatment of Non-Small Cell Lung Cancer and the Effects of Cytoprotective Strategies
2005
Heating the patient: a promising approach?
2002 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
1999
Reported management of lung cancer in Victoria in 1993: comparison with best practice
2000
Defining treatment margins for six field conformal irradiation of localized prostate cancer
1994
Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma
2001
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
2010 Standout
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in rtog 88-08/ECOG 4588
1997
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer
2000
Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non–Small-Cell Lung Cancer (NSCLC)
2008
Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies
2002
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer
2001
Induction chemotherapy and radiotherapy in locally advanced non–small cell lung cancer
2004
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Cancers bronchiques non à petites cellules : amélioration des chances de survie par la radiothérapie conformationnelle ?
2002
The cellular and molecular basis of hyperthermia
2002 Standout
Accelerated Hyperfractionation in Patients with Non-Small Cell Bronchogenic Cancers as a Cost-Effective and User- and Patient-Friendly Schedule
2000
Soft-Tissue Sarcomas in Adults
2005 Standout
Dose escalation of chart in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary?
1999
Status of Clinical Hyperthermia
1999
Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma
2005
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial
1997
Conformity index: A review
2006 Standout
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
The deep inspiration breath-hold technique in the treatment of inoperable non–small-cell lung cancer
2000
Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: Prognostic factors in 196 tumors
1998
Lung cancer: current therapies and new targeted treatments
2016 Standout
Ten-year survey of lung cancer treatment and survival in hospitals in the United States
1999
Small‐volume image‐guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas
2002
Clinical and Surgical Staging of Non-Small Cell Lung Cancer
2000
Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists
2002
Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors
2002
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer
2001
Transesophageal Echographic Determination of Aortic Invasion by Lung Cancer
2005
Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect
1996
Clinical experience using 8 MHZ radiofrequency capacitive hyperthermia in combination with radiotherapy: Results of a phase study
1995
Low dose reirradiation in combination with hyperthermia: A palliative treatment for patients with breast cancer recurring in previously irradiated areas
1988
Hyperthermia, Radiation and Chemotherapy: The Role of Heat in Multidisciplinary Cancer Care
2014
Partial irradiation of the rectum
2001
Effect of filgrastim (G-CSF) in hodgkin's disease patients treated with radiation therapy
1994
Combined hyperthermia and irradiation in the treatment of superficial tumors: results of a prospective randomized trial of hyperthermia fractionation (1/wk vs 2/wk)
1992
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
2000
Sonodynamic therapy––a review of the synergistic effects of drugs and ultrasound
2004
Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial
1996
Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer
2000
The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy
2000 Standout
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
2009
Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
1999
A Phase III Randomized Trial of Combined Chemoradiotherapy Versus Radiotherapy Alone in Locally Advanced Non–Small-Cell Lung Cancer
2002
Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer
1997
Hyperthermia in the Multimodal Therapy of Advanced Rectal Carcinomas
1996
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Revisions in the International System for Staging Lung Cancer
1997 Standout
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy
2002
A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer
2004
Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer
2002
Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06
1988
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
2006 Standout
Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer
1998
Evaluation of microscopic tumor extension in non–small-cell lung cancer for three-dimensional conformal radiotherapy planning
2000
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706
1991
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
2011
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Water-Soluble Iron Oxide Nanocubes with High Values of Specific Absorption Rate for Cancer Cell Hyperthermia Treatment
2012
Head and Neck Cancer
2020 Standout
Nanoparticles for photothermal therapies
2014 Standout
Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique
2005
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Liposomal Doxorubicin and Conventionally Fractionated Radiotherapy in the Treatment of Locally Advanced Non–Small-Cell Lung Cancer and Head and Neck Cancer
1999
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma
2001
Radiation therapy alone for stage I non-small cell lung cancer
1993
Decision aids for people facing health treatment or screening decisions
2017 Standout
Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life
1999
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
2009 Standout
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: A Preliminary Report of a Phase I Dose Escalation Trial from the Carolina Conformal Therapy Consortium
2001
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
1999
Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma
1999
The role of radiotherapy in cancer treatment
2005 Standout
The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics.
2001
New photosensitizers for photodynamic therapy
2016 Standout
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
1998
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
1999
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: Report of a Prospective Phase I Dose Escalation Trial From the Carolina Conformal Therapy Consortium
2004
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Phase I Study of a Decision Aid for Patients With Locally Advanced Non–Small-Cell Lung Cancer
2001
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Concurrent Cisplatin, Etoposide, and Chest Radiotherapy in Pathologic Stage IIIB Non–Small-Cell Lung Cancer: A Southwest Oncology Group Phase II Study, SWOG 9019
2002
Variable management of soft tissue sarcoma: Regional audit with implications for specialist care
1997
Thermoradiotherapy in the management of superficial malignant tumors.
1995
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413
2003
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma
1998
Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial
2001
Works of B. Emami being referenced
Regional Hyperthermia in Patients with Recurrent Genitourinary Cancer
1991
Equilibrium temperature distributions in uniform phantoms for superficial microwave applicators: Implications for temperature-based standards of applicator adequacy
1992
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer
1995
Interaction of bleomycin and hyperthermia-results of a clinical pilot study
1989
Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation.
1989
SAR patterns of external 915 MHz microwave applicators
1990
Quality control in NSCLC treatment: a consensus report
1991
Interruptions of high-dose radiation therapy for non-small cell carcinoma of the lung decrease long-term survival in favorable patients
1992
Effects of single-dose irradiation in tumor blood flow studied by 15O decay after proton activation in situ.
1981
Correlation of radiotherapeutic parameters and treatment related morbidity—analysis of RTOG study 77-06
1987
The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)
1992
Clinical trials with local (external and interstitial) irradiation and hyperthermia. Current and future perspectives.
1989
Difficulties in assessing therapeutic results of clinical hyperthermia in an RTOG trial
1987
Radical prostatectomy or radiotherapy in carcinoma of prostate
1987
Evaluation of the Sigma 60 applicator for regional hyperthermia in terms of scattering parameters
1991
Three-dimensional conformal radiation therapy in bronchogenic carcinoma
1996
3-D radiation treatment planning study for patients with carcinoma of the lung
1992
Management of soft tissue sarcomas of the extremities.
1991